OP5-005 Using Omnipod 5 in Adults With Type 2
Public ClinicalTrials.gov record NCT05815342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes
Study identification
- NCT ID
- NCT05815342
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Insulet Corporation
- Industry
- Enrollment
- 343 participants
Conditions and interventions
Conditions
Interventions
- Omnipod 5 Automated Glucose Control System Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 10, 2023
- Primary completion
- Feb 29, 2024
- Completion
- Feb 29, 2024
- Last update posted
- Sep 28, 2025
2023 – 2024
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90022 | — |
| Sansum Diabetes Research Institute | Santa Barbara | California | 93105 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| East Coast Institute for Research | Jacksonville | Florida | 32216 | — |
| Metabolic Research Institute | West Palm Beach | Florida | 33401 | — |
| Emory | Atlanta | Georgia | 30303 | — |
| East Coast Institute for Research | Canton | Georgia | 30114 | — |
| Endocrine Research | Roswell | Georgia | 30076 | — |
| Joslin Diabetes | Boston | Massachusetts | 02215 | — |
| Henry Ford | Detroit | Michigan | 48202 | — |
| Health Partners | Minneapolis | Minnesota | 55416 | — |
| Albert Einstein College of Medicine | The Bronx | New York | 10461 | — |
| MAHEC | Asheville | North Carolina | 28803 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| Physicians East | Greenville | North Carolina | 27834 | — |
| AccellaCare | Wilmington | North Carolina | 28401 | — |
| Ohio State | Columbus | Ohio | 43203 | — |
| University Diabetes and Endocrine Consultants | Chattanooga | Tennessee | 37411 | — |
| Texas Diabetes and Endocrinology | Austin | Texas | 78731 | — |
| Diabetes and Thyroid Center | Fort Worth | Texas | 76132 | — |
| Diabetes and Glandular Disease Clinic | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05815342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05815342 live on ClinicalTrials.gov.